# Alpaca Model Training - Analysis Report
**Generated:** 2025-10-30 14:36
**Study:** cappuccino_alpaca
**Status:** In Progress (22.3% complete)

---

## Executive Summary

Training is progressing excellently with **strong statistical evidence of improvement**. After 67 completed trials, the optimization shows a statistically significant upward trend (Spearman ρ=+0.406, p<0.001). Current best trial achieves Sharpe Δ of +0.045215, which is acceptable for paper trading validation.

**Key Verdict:** ✅ **CONTINUE TRAINING TO COMPLETION**

---

## Current Status

### Progress Metrics
- **Completed:** 67 / 300 trials (22.3%)
- **Running:** 3 trials in parallel
- **GPU Utilization:** 97% (excellent)
- **Throughput:** 13-14 trials/hour
- **Est. Completion:** ~17 hours (tomorrow ~8:00 AM)

### Performance Metrics
```
Best Trial:       #65
Best Sharpe Δ:    +0.045215
Mean:            +0.029751 ± 0.024759
Median:          +0.039666
Range:           [-0.059136 to +0.045215]
```

### Comparison to Original Trial #13
```
Trial #13 (Original):  +0.077980
Current Best (#65):    +0.045215
Difference:            -0.032765 (-42% lower)
```

⚠️ **Note:** Lower performance is expected due to:
- Different ticker composition (Alpaca-compatible vs original)
- Different data sources and environment
- This is precisely why we're training a new model

---

## Statistical Analysis

### 1. Trend Detection ✅ POSITIVE
```
Spearman Correlation: +0.406 (p=0.0006) ***
Interpretation:       Strong positive monotonic trend
Significance:         Highly significant (p < 0.001)

Performance Evolution:
  Early trials avg:   +0.014249
  Middle trials avg:  +0.034930
  Recent trials avg:  +0.039518

Overall improvement:  +178% (early to recent)
```

**Interpretation:** Optimization is working correctly. Later trials systematically outperform earlier ones, indicating successful Bayesian parameter space narrowing.

### 2. Convergence Status
```
Trials since best:    1 (just found)
Recent 10 avg:       +0.038838
Gap to best:         -0.006377 (-14%)
Volatility ratio:    0.52x (stabilizing)
```

**Interpretation:** Recently found new best. Still room for improvement but variance is decreasing.

### 3. Momentum Analysis
```
MA(5):   +0.043577  (↑ +0.019960 trend)
MA(10):  +0.038838  (↑ +0.022673 trend)
```

Both moving averages show strong upward momentum. Short-term MA > long-term MA indicates acceleration.

### 4. Statistical Tests
```
Mean shift:     Detected (p=0.0007) ***
Autocorr(1):    +0.454
Persistence:    High (parameters exploring coherent region)
```

**Interpretation:** Performance improvements are real and statistically significant, not random noise.

---

## Critical Analysis

### Why Lower Than Trial #13?

**1. Different Asset Universe**
- **Original:** BTC, ETH, DOGE, ADA, SOL, MATIC, DOT
- **Current:** BTC, ETH, LTC, BCH, LINK, UNI, AAVE
- Different correlation structures
- Different volatility profiles
- Some Alpaca tickers (BCH, LTC) may be less suitable for ML trading

**2. Environment Differences**
- Data source differences (original vs Alpaca)
- Technical indicator calculation differences
- This is the exact reason we had model-environment mismatch earlier

**3. Market Regime**
- Training data may span different market conditions
- Crypto markets are highly non-stationary

### Is 0.045 Good Enough?

**Industry Context:**
```
Sharpe Ratio Benchmarks (annualized):
  Crypto HODL:        ~0.3 to 1.0 (highly variable)
  Good Algo Trading:  > 0.5
  Excellent:          > 1.0
  Elite:              > 2.0

Current (if annualized): ~0.045 * sqrt(365*24) ≈ 0.86
```

**Verdict:** Acceptable for paper trading validation. Not elite, but respectable for 1-hour timeframe crypto trading.

---

## Projections

### Timeline to Completion
```
Current:       Trial #67/300 (22.3%)
Remaining:     233 trials
Rate:          13.4 trials/hour (3 parallel)
Time left:     ~17.4 hours
Expected done: 2025-10-31 ~8:00 AM

Milestones:
  Trial #100:  ~6h  (tonight ~8:30 PM)
  Trial #150:  ~12h (tomorrow ~2:30 AM)
  Trial #200:  ~18h (tomorrow ~8:30 AM)
  Trial #300:  ~24h (tomorrow ~2:30 PM)
```

### Expected Final Performance
Based on current trend trajectory:
```
Conservative estimate:  0.050-0.055
Optimistic estimate:    0.055-0.060
Breakthrough scenario:  0.060-0.070 (if finds new parameter region)
```

**Most likely:** Final best will be in 0.050-0.055 range.

---

## Recommendations

### Immediate Actions (Now)
✅ **Continue training** - Strong upward trend, still improving
✅ **Monitor GPU** - Currently excellent at 97%
✅ **No intervention needed** - System is healthy

### At Trial #100 (~6 hours)
- [ ] Check convergence status
- [ ] Verify trend continuation
- [ ] Assess if on track for >0.050

### At Trial #150 (~12 hours)
- [ ] Evaluate plateau indicators
- [ ] If converged >0.050: Can deploy early
- [ ] If stuck <0.045: Consider search space expansion

### At Trial #200 (~18 hours)
- [ ] Final convergence check
- [ ] If strong convergence: Can stop early
- [ ] If still improving: Continue to 300

### Deployment Decision Tree
```
If final best >0.055:  ✅ Deploy to paper trading immediately
If final best 0.050-0.055:  ✅ Deploy with monitoring
If final best 0.045-0.050:  ⚠️ Deploy cautiously, watch closely
If final best <0.045:  ❌ Consider retraining with different params
```

---

## Technical Insights

### What's Working Well
1. **Strong positive trend** - Optimization is effective
2. **High GPU utilization** - Parallel training efficient
3. **Stable convergence** - Decreasing volatility
4. **Statistical significance** - Real improvements, not luck

### Parameter Space Observations
From Trial #65 (current best):
```
learning_rate:  0.000002 (2e-6)  [low, stable learning]
batch_size:     1536             [smaller batch for exploration]
gamma:          0.98             [high future reward weight]
net_dimension:  1536             [matched with batch size]
```

Pattern: Best trials favor **low learning rate + moderate batch size + high gamma**

### Areas for Improvement
1. Ticker selection may not be optimal
2. Could try 4h timeframe instead of 1h
3. May need more sophisticated features

---

## Comparison: Trial #13 vs Current Best

| Metric | Trial #13 (Original) | Trial #65 (Alpaca) | Difference |
|--------|---------------------|-------------------|------------|
| Sharpe Δ | +0.077980 | +0.045215 | -42% |
| Tickers | 7 (mixed) | 7 (Alpaca) | Different |
| Learning Rate | 1.33e-6 | 2.0e-6 | +50% |
| Batch Size | 3072 | 1536 | -50% |
| Gamma | 0.98 | 0.98 | Same |
| Net Dim | 1536 | 1536 | Same |

**Key Difference:** Smaller batch size in current best vs Trial #13.

---

## Risk Assessment

### Training Risks
- ✅ **Low Risk:** Training is stable and progressing
- ✅ **GPU:** No memory issues
- ✅ **Convergence:** On track
- ⚠️ **Performance:** Lower than Trial #13 but acceptable

### Deployment Risks
- ⚠️ **Moderate:** Sharpe 0.045 is decent but not exceptional
- ⚠️ **Overfitting:** 300 trials may overfit to training data
- ✅ **Backtesting:** Will validate before paper trading
- ✅ **Paper Trading:** 2-week test before any live deployment

**Overall Risk:** **MODERATE** - Acceptable for paper trading, monitor closely

---

## Next Steps

### After Training Completes
1. **Identify Best Trial** (will be auto-saved in database)
2. **Extract Best Model** from `train_results/cwd_tests/trial_XX_1h/`
3. **Backtest** on out-of-sample historical data
4. **Forward Validate** on recent market data (last 2-4 weeks)
5. **Paper Trade** for 2+ weeks minimum
6. **Analyze Paper Results** before considering live deployment

### Monitoring Commands
```bash
# Real-time monitor
python monitor.py --study-name cappuccino_alpaca

# Check specific trial
python monitor.py --study-name cappuccino_alpaca --trial 65

# Database query
sqlite3 optuna_cappuccino.db "SELECT number, value FROM trials ORDER BY value DESC LIMIT 10;"

# GPU check
nvidia-smi
```

---

## Appendix: Statistical Details

### Econometric Tests Performed
1. **Spearman Rank Correlation:** Monotonic trend detection
2. **Mann-Shift Test:** Mean shift detection between periods
3. **Autocorrelation Analysis:** Parameter persistence
4. **Moving Averages:** Short vs long-term momentum
5. **Volatility Analysis:** Convergence stability

### Significance Levels
- *** p < 0.001 (highly significant)
- **  p < 0.01  (very significant)
- *   p < 0.05  (significant)

### Data Quality
- No missing trials
- No failed trials
- All 67 completed trials valid
- No outliers removed

---

## Conclusion

Training is **progressing excellently** with strong statistical evidence of systematic improvement. While performance is lower than the original Trial #13, this is expected and acceptable given the different environment and ticker composition.

**Recommendation:** Continue training to completion. Expected final performance (Sharpe Δ ~0.050-0.055) is suitable for paper trading validation.

The strong positive trend (ρ=+0.406, p<0.001) indicates the optimization is working correctly and still finding better parameter combinations.

---

**Report Generated:** 2025-10-30 14:36
**Next Review:** Trial #100 (~6 hours)
**Status:** ✅ GREEN - No action required

